On March 14, 2025, ANI Pharmaceuticals announced that the FDA approved an expanded label for ILUVIEN to treat chronic non-infectious uveitis affecting the eye.
AI Assistant
ANI PHARMACEUTICALS INC
2025
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.